Human Genetic Mutant Cell Repository is categorized under Medical Research in Camden, NJ and active since 1953.
Human Genetic Mutant Cell Repository was established in 1953, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact David P Beck at the company’s single location by writing to 403 Haddon Avenue, Camden, New Jersey NJ 08103 or by phoning (856) 757-4848. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Human Genetic Mutant Cell Repository |
Contact Person: | David P Beck |
Address: | 403 Haddon Avenue, Camden, New Jersey 08103 |
Phone Number: | (856) 757-4848 |
Website Address: | coriell.org |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1953 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Human Genetic Mutant Cell Repository was started in 1953 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David P Beck for inquiries that concern Human Genetic Mutant Cell Repository by calling the company number (856) 757-4848, as your correspondence is most welcome. Additionally, the physical location of the single location of Human Genetic Mutant Cell Repository can be found at the coordinates 39.940438,-75.114476 as well as the street address 403 Haddon Avenue in Camden, New Jersey 08103.
For its online presence, you may visit Human Genetic Mutant Cell Repository’s website at coriell.org and engage with its social media outlets through on Twitter and on Facebook.